Identification of plasma protein profiles associated with risk groups of prostate cancer patients.
Research output: Contribution to journal › Article
Early detection of prostate cancer (PC) using prostate-specific antigen (PSA) in blood reduces PC-death among unscreened men. However, due to modest specificity of PSA at commonly used cut-offs, there are urgent needs for additional biomarkers contributing enhanced risk classification among men with modestly elevated PSA.
|Research areas and keywords||
Subject classification (UKÄ) – MANDATORY
|Journal||Proteomics Clinical Applications|
|Publication status||Published - 2014|
No data available